Report Summary
Eternity Insights has published a new study on Global Healthcare Contract Research Organization (CRO) Market focusing on key segments as by Type (Early-phase development services, Clinical research services, Laboratory services, Consulting service), by Application (Pharmaceutical and biopharmaceutical companies, Medical device companies, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Healthcare Contract Research Organization (CRO) Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Healthcare Contract Research Organization (CRO) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Healthcare Contract Research Organization (CRO) Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Healthcare Contract Research Organization (CRO) Market Segmentation:
Healthcare Contract Research Organization (CRO) Market, By Type
- Early-phase development services
- Clinical research services
- Laboratory services
- Consulting service
Healthcare Contract Research Organization (CRO) Market, By Application
- Pharmaceutical and biopharmaceutical companies
- Medical device companies
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Healthcare Contract Research Organization (CRO) market in terms of demand generation. The Healthcare Contract Research Organization (CRO) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Healthcare Contract Research Organization (CRO) market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Healthcare Contract Research Organization (CRO) Market Taxonomy:
To learn more about this report
Global Healthcare Contract Research Organization (CRO) Market Competitive Landscape
The global Healthcare Contract Research Organization (CRO) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Charles River Laboratories(CRL)
- Clinipace
- Clinitec
- CMIC
- EPS
- ICON
- Laboratory Corporation of America Holdings (Covance)
- Medpace
- Parexel
- Pharmaceutical Product Development (PDD)
- PRA Health Sciences
- IQVIA (Quintiles IMS)
- Syneos Health
- Synteract
- Worldwide Clinical Trials
- Wuxi AppTec
- Others
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Early-phase development services, Clinical research services, Laboratory services, Consulting service |
| By Application Outlook |
Pharmaceutical and biopharmaceutical companies, Medical device companies, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Charles River Laboratories(CRL), Clinipace, Clinitec, CMIC, EPS, ICON, Laboratory Corporation of America Holdings (Covance), Medpace, Parexel, Pharmaceutical Product Development (PDD), PRA Health Sciences, IQVIA (Quintiles IMS), Syneos Health, Synteract, Worldwide Clinical Trials, Wuxi AppTec, Others |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Healthcare Contract Research Organization (CRO) Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Healthcare Contract Research Organization (CRO) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Early-phase development services Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Clinical research services Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Laboratory services Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Consulting service Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Healthcare Contract Research Organization (CRO) Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Healthcare Contract Research Organization (CRO) Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Healthcare Contract Research Organization (CRO) Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Healthcare Contract Research Organization (CRO) Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Healthcare Contract Research Organization (CRO) Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Healthcare Contract Research Organization (CRO) Market Assessment by Type
8.1 Asia Pacific Healthcare Contract Research Organization (CRO) Market Assessment by Application (Consumption and Market Share)
8.2 North America Healthcare Contract Research Organization (CRO) Market Assessment by Application (Consumption and Market Share)
8.3 Europe Healthcare Contract Research Organization (CRO) Market Assessment by Application (Consumption and Market Share)
8.4 South America Healthcare Contract Research Organization (CRO) Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Healthcare Contract Research Organization (CRO) Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Charles River Laboratories(CRL)
9.1.1 Charles River Laboratories(CRL) Profiles
9.1.2 Charles River Laboratories(CRL) Product Portfolio
9.1.3 Charles River Laboratories(CRL) Healthcare Contract Research Organization (CRO) Business Performance
9.1.4 Charles River Laboratories(CRL) Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.2 Clinipace
9.2.1 Clinipace Profiles
9.2.2 Clinipace Product Portfolio
9.2.3 Clinipace Healthcare Contract Research Organization (CRO) Business Performance
9.2.4 Clinipace Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.3 Clinitec
9.3.1 Clinitec Profiles
9.3.2 Clinitec Product Portfolio
9.3.3 Clinitec Healthcare Contract Research Organization (CRO) Business Performance
9.3.4 Clinitec Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.4 CMIC
9.4.1 CMIC Profiles
9.4.2 CMIC Product Portfolio
9.4.3 CMIC Healthcare Contract Research Organization (CRO) Business Performance
9.4.4 CMIC Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.5 EPS
9.5.1 EPS Profiles
9.5.2 EPS Product Portfolio
9.5.3 EPS Healthcare Contract Research Organization (CRO) Business Performance
9.5.4 EPS Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.6 ICON
9.6.1 ICON Profiles
9.6.2 ICON Product Portfolio
9.6.3 ICON Healthcare Contract Research Organization (CRO) Business Performance
9.6.4 ICON Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.7 Laboratory Corporation of America Holdings (Covance)
9.7.1 Laboratory Corporation of America Holdings (Covance) Profiles
9.7.2 Laboratory Corporation of America Holdings (Covance) Product Portfolio
9.7.3 Laboratory Corporation of America Holdings (Covance) Healthcare Contract Research Organization (CRO) Business Performance
9.7.4 Laboratory Corporation of America Holdings (Covance) Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.8 Medpace
9.8.1 Medpace Profiles
9.8.2 Medpace Product Portfolio
9.8.3 Medpace Healthcare Contract Research Organization (CRO) Business Performance
9.8.4 Medpace Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.9 Parexel
9.9.1 Parexel Profiles
9.9.2 Parexel Product Portfolio
9.9.3 Parexel Healthcare Contract Research Organization (CRO) Business Performance
9.9.4 Parexel Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.10 Pharmaceutical Product Development (PDD)
9.10.1 Pharmaceutical Product Development (PDD) Profiles
9.10.2 Pharmaceutical Product Development (PDD) Product Portfolio
9.10.3 Pharmaceutical Product Development (PDD) Healthcare Contract Research Organization (CRO) Business Performance
9.10.4 Pharmaceutical Product Development (PDD) Healthcare Contract Research Organization (CRO) Business Development and Market Status
9.11 PRA Health Sciences
9.12 IQVIA (Quintiles IMS)
9.13 Syneos Health
9.14 Synteract
9.15 Worldwide Clinical Trials
9.16 Wuxi AppTec
9.17 Others
10 World Healthcare Contract Research Organization (CRO) Market Assessment by Players
10.1 Global Healthcare Contract Research Organization (CRO) Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Healthcare Contract Research Organization (CRO) Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Healthcare Contract Research Organization (CRO) Price (USD/Unit) of Players 2014-2020
10.4 Global Healthcare Contract Research Organization (CRO) Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Healthcare Contract Research Organization (CRO) Sales Assessment of Players 2014-2020
11.1.2 North America Healthcare Contract Research Organization (CRO) Revenue Assessment of Players 2014-2020
11.1.3 North America Healthcare Contract Research Organization (CRO) Price Assessment of Players 2014-2020
11.1.4 North America Healthcare Contract Research Organization (CRO) Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Healthcare Contract Research Organization (CRO) Sales Assessment of Players 2014-2020
11.2.2 Europe Healthcare Contract Research Organization (CRO) Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Healthcare Contract Research Organization (CRO) Price Assessment of Players 2014-2020
11.2.4 Europe Healthcare Contract Research Organization (CRO) Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Healthcare Contract Research Organization (CRO) Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Healthcare Contract Research Organization (CRO) Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Healthcare Contract Research Organization (CRO) Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Healthcare Contract Research Organization (CRO) Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Healthcare Contract Research Organization (CRO) Sales Assessment of Players 2014-2020
11.4.2 South America Healthcare Contract Research Organization (CRO) Revenue Assessment of Players 2014-2020
11.4.3 South America Healthcare Contract Research Organization (CRO) Price Assessment of Players 2014-2020
11.4.4 South America Healthcare Contract Research Organization (CRO) Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Healthcare Contract Research Organization (CRO) Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Healthcare Contract Research Organization (CRO) Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Healthcare Contract Research Organization (CRO) Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Healthcare Contract Research Organization (CRO) Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Healthcare Contract Research Organization (CRO) Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Healthcare Contract Research Organization (CRO) Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Healthcare Contract Research Organization (CRO) Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Healthcare Contract Research Organization (CRO) Sales by Countries/Regions 2014-2020
12.2.2 North America Healthcare Contract Research Organization (CRO) Revenue by Countries/Regions 2014-2020
12.2.3 North America Healthcare Contract Research Organization (CRO) Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Healthcare Contract Research Organization (CRO) Sales by Countries/Regions 2014-2020
12.3.2 Europe Healthcare Contract Research Organization (CRO) Revenue by Countries/Regions 2014-2020
12.3.3 Europe Healthcare Contract Research Organization (CRO) Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Healthcare Contract Research Organization (CRO) Sales by Countries/Regions 2014-2020
12.4.2 South America Healthcare Contract Research Organization (CRO) Revenue by Countries/Regions 2014-2020
12.4.3 South America Healthcare Contract Research Organization (CRO) Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Healthcare Contract Research Organization (CRO) Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Healthcare Contract Research Organization (CRO) Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Healthcare Contract Research Organization (CRO) Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Healthcare Contract Research Organization (CRO) Sales & Revenue Forecast 2021-2026
14.1 World Healthcare Contract Research Organization (CRO) Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Healthcare Contract Research Organization (CRO)Sales and Market Share by Regions
14.1.2 World Healthcare Contract Research Organization (CRO)Revenue and Market Share by Regions
15 Asia Healthcare Contract Research Organization (CRO) Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Early-phase development services
15.1.2 Clinical research services
15.1.3 Laboratory services
15.1.4 Consulting service
15.2 Consumption Forecast by Application, 2021-2026
16 North America Healthcare Contract Research Organization (CRO) Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Early-phase development services
16.1.2 Clinical research services
16.1.3 Laboratory services
16.1.4 Consulting service
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Healthcare Contract Research Organization (CRO) Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Early-phase development services
17.1.2 Clinical research services
17.1.3 Laboratory services
17.1.4 Consulting service
17.2 Consumption Forecast by Application, 2021-2026
18 South America Healthcare Contract Research Organization (CRO) Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Early-phase development services
18.1.2 Clinical research services
18.1.3 Laboratory services
18.1.4 Consulting service
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Healthcare Contract Research Organization (CRO) Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Early-phase development services
19.1.2 Clinical research services
19.1.3 Laboratory services
19.1.4 Consulting service
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Healthcare Contract Research Organization (CRO) Price (USD/Unit) Trend 2021-2026
20.2 Global Healthcare Contract Research Organization (CRO) Gross Profit Trend 2021-2026
21 Conclusion
